Wall street… tweaks
The analog of psilocybin that Gilgamesh is developing has been designed to eliminate the hallucinogenic experiences that are often set off by so-called magic mushrooms. Researchers working with the company [including team members from ATAI, Pfizer, Johnson & Johnson, etc], administer test drugs [new chemical entities] to mice and then capture their reactions using video…











Recent Comments